WallStreetZenWallStreetZen

NYSE: HAE
Haemonetics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Haemonetics revenue was $1.37B for the trailing 12 months ending Dec 28, 2024, with 2.4% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 28, 2024 was $348.5M, up 0.9% from last quarter. For the last reported fiscal year 2024 ending Mar 30, 2024, HAE annual revenue was $1.3B, with 12% growth year-over-year.

HAE past revenue growth

How has HAE's revenue growth performed historically?

Company
8.14%
Industry
10.75%
Market
20.27%
HAE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HAE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HAE's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HAE revenue history

Current Revenue
$1.4B
Current Earnings
$130.1M
Current Profit Margin
9.5%
HAE's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when HAE announces revenue.

HAE Revenue History By Year

HAE Yearly RevenueHAE RevenueHAE ChangeHAE Revenue Growth
2024-03-30$1.31B$140.40M+12.01%
2023-04-01$1.17B$175.46M+17.67%
2022-04-02$993.20M$122.73M+14.10%
2021-04-03$870.46M-$118.02M-11.94%
2020-03-28$988.48M$20.90M+2.16%
2019-03-30$967.58M$63.66M+7.04%
2018-03-31$903.92M$17.81M+2.01%
2017-04-01$886.12M-$22.72M-2.50%
2016-04-02$908.83M-$1.54M-0.17%
2015-03-28$910.37M-$28.14M-3.00%
2014-03-29$938.51M$46.52M+5.22%
2013-03-30$891.99M$164.15M+22.55%
2012-03-31$727.84M$51.15M+7.56%
2011-04-02$676.69M$31.26M+4.84%
2010-04-03$645.43M$47.55M+7.95%
2009-03-28$597.88M$81.44M+15.77%
2008-03-29$516.44M$66.83M+14.86%
2007-03-31$449.61M$29.87M+7.12%
2006-04-01$419.73M$36.14M+9.42%
2005-04-02$383.60M$19.37M+5.32%
2004-04-03$364.23M$27.27M+8.09%
2003-03-29$336.96M$16.99M+5.31%
2002-03-30$319.97M$26.11M+8.88%
2001-03-31$293.86M$13.25M+4.72%
2000-04-01$280.61M-$3.90M-1.37%
1999-04-03$284.51M-$1.25M-0.44%
1998-03-28$285.76M-$17.25M-5.69%
1997-03-29$303.01M$26.54M+9.60%
1996-03-30$276.47M$14.05M+5.36%
1995-04-01$262.42MN/AN/A

1 of 2

Haemonetics Revenue FAQ

What was HAE's revenue last quarter?

On Invalid Date, Haemonetics (NYSE: HAE) reported Q4 2024 revenue of $348.54 million up 3.66% year over year. In the same quarter last year, Haemonetics's revenue was $336.25 million.

What was Haemonetics's revenue in 2024?

Haemonetics's annual revenue for the twelve months ending Mar 30, 2024 was $1.31 billion, a 12.01% increase year over year.

How much does Haemonetics make in a day?

Based on Haemonetics annual revenue for the past five years, HAE makes an average of $2,920,467.40 per day.

What was Haemonetics's annual revenue growth in the past year?

As of Q2 2025, Haemonetics's revenue has grown 8.14% year over year. This is 2.61 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 10.75%. Haemonetics's revenue in the past year totaled $1.37 billion.

How much does Haemonetics make in a year?

Haemonetics's revenue by year for the past five years is:
  • Haemonetics's revenue for the twelve months ending Mar 30, 2024 was $1.31 billion, a 12.01% increase year over year.
  • Haemonetics's annual revenue for Apr 1, 2023 was $1.17 billion, a 17.67% increase from 2022.
  • Haemonetics's annual revenue for 2022 was $993.20 million, a 14.1% increase from 2021.
  • Haemonetics's annual revenue for 2021 was $870.46 million, a 11.94% decrease from 2020.
  • Haemonetics's annual revenue for 2020 was $988.48 million, a 2.16% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.